Trials / Withdrawn
WithdrawnNCT01710462
Clinical Study, Multicenter, Randomized With 2 Arms of Pantoprazole + Domperidone and Pantoprazole Isolated at the Gastroesophageal Reflux Disease
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Eurofarma Laboratorios S.A. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This superiority phase III study to compare the combination of Pantoprazole and Domperidone with Pantoprazole isolated to the treatment of gastroesophageal reflux disease. The hypothesis is that combination of the two medication at the unique capsule is better to the patients because decrease the quantity of times the patients need to take medicines during the day.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pantoprazole + Domperidone | |
| DRUG | Pantozol® |
Timeline
- Start date
- 2013-08-01
- First posted
- 2012-10-19
- Last updated
- 2015-07-24
Locations
8 sites across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01710462. Inclusion in this directory is not an endorsement.